Tag: high-grade serous ovarian cancer

New research shows that high-grade serous ovarian cancer cells can convert abundant adrenal 11-oxyandrogen precursors into the potent androgen 11-keto-testosterone, ...

A personalized dendritic cell neoantigen vaccine given to an ovarian cancer patient enabled Swiss researchers to track expanding T-cell clonotypes ...

In a finding that could reshape the search for new treatments against one of the deadliest gynecologic malignancies, researchers in ...

In the intricate landscape of cancer research, the relentless pursuit of understanding metastatic mechanisms has garnered significant attention. Recent findings ...

In the evolving landscape of cancer research, the challenge of treating high-grade serous ovarian cancer (HGSOC) has presented ongoing dilemmas ...

In a groundbreaking study soon to be published in Scientific Reports, researchers Xu, Wang, and Wu, along with their team, ...

In a groundbreaking study set to transform ovarian cancer diagnostics and therapies, researchers have unveiled the critical role of phospholipase ...

In a groundbreaking study published in the Journal of Ovarian Research, researchers have unveiled an innovative approach to combatting chemoresistant ...

A groundbreaking study has unveiled the dynamic clonal evolution of high-grade serous ovarian cancer (HGSOC) during treatment by leveraging the ...

High-grade serous ovarian cancer (HGSOC) remains one of the most lethal gynecologic malignancies, owing to its tendency for early microscopic ...